Hipromine (WAR:HPM) Change In Receivables: zł-1.13 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:HPM Hipromine SA WAR:HPM
55 GF Score
Price zł65.00
GF Value zł520.38
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is Hipromine Change In Receivables?

Hipromine WAR:HPM -2.26% 55 Change In Receivables is zł-1.13 Mil as of Jun. 2026. GuruFocus rates WAR:HPM with a GF Score™ of 55/100 and a GF Value™ of zł520.38 (Possible Value Trap). The stock has 8 warning signs investors should review.

Hipromine's change in receivables for the quarter that ended in Jun. 2026 was zł0.26 Mil. It means Hipromine's Accounts Receivable declined by zł0.26 Mil from Mar. 2026 to Jun. 2026 .

Hipromine's change in receivables for the fiscal year that ended in Dec. 2025 was zł-0.07 Mil. It means Hipromine's Accounts Receivable increased by zł0.07 Mil from Dec. 2024 to Dec. 2025 .

Hipromine's Accounts Receivable for the quarter that ended in Jun. 2026 was zł1.77 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Hipromine's Days Sales Outstanding for the three months ended in Jun. 2026 was 47.82.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Hipromine's liquidation value for the three months ended in Jun. 2026 was zł-195.17 Mil.

Hipromine  (WAR:HPM) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Hipromine's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=1.766/3.37*91
=47.82

2. In Ben Graham's calculation of liquidation value, Hipromine's accounts receivable are only considered to be worth 75% of book value:

Hipromine's liquidation value for the quarter that ended in Jun. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=9.672-209.844+0.75 * 1.766+0.5 * 7.357
=-195.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hipromine Change In Receivables Related Terms

Hipromine Change In Receivables Historical Data

* Premium members only.

The historical data trend for Hipromine's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hipromine Change In Receivables Chart

Hipromine Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Receivables
Get a 7-Day Free Trial 0.07 -0.64 -14.30 12.30 -0.07

Hipromine Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.25 0.51 -0.87 -1.03 0.26
WAR:HPM
55GF Score
Hipromine SA WAR:HPM
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hipromine Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-1.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of zł-1.13 Mil mean?
Hipromine (WAR:HPM) has a Change In Receivables of zł-1.13 Mil as of Jun. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Hipromine and its competitors.
Is Hipromine's Change In Receivables too high?
Hipromine's current Change In Receivables is zł-1.13 Mil. Overall, Hipromine has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Hipromine's Change In Receivables compare to KHC and GIS?
Hipromine's Change In Receivables of zł-1.13 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Consumer Packaged Goods company?
A good Change In Receivables depends on the Consumer Packaged Goods industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Hipromine and its competitors. Hipromine's current Change In Receivables is zł-1.13 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hipromine stock overvalued right now?
Based on GuruFocus' analysis, Hipromine (WAR:HPM) is currently considered Possible Value Trap. The stock's GF Value™ is zł520.38, compared to a current price of zł65.00 — trading 87.5% below its estimated fair value. The current Change In Receivables is zł-1.13 Mil. Hipromine's overall GF Score™ is 55/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Hipromine (WAR:HPM), the current Change In Receivables is zł-1.13 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hipromine (WAR:HPM) Overvalued in 2026?

Based on GuruFocus' analysis, Hipromine stock appears to be undervalued. The current stock price of zł65.00 is trading 87.5% below its estimated GF Value™ of zł520.38. GuruFocus considers Hipromine to be Possible Value Trap.

Key valuation signals for WAR:HPM:

  • Change In Receivables: zł-1.13 Mil
  • GF Value™: zł520.38 vs. price of zł65.00 (87.5% below fair value)
  • GF Score™: 55/100 with 8 warning signs

No single metric tells the full story. See the WAR:HPM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hipromine Business Description

Address ul. Poznańska, 12th Floor, Robakowo, POL, 62-023
Hipromine SA is a European scale supplier of an alternative protein produced through innovative, proprietary technology of industrial insect breeding. The company's offer is directed mainly to the market of pet food and fodder for fish farming, as well as livestock and horticulture.
55GF Score

Get the complete analysis for WAR:HPM

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł65.00
Price
zł520.38
GF Value